Pfizer ( PFE -1.82%) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on ...

After you've had COVID-19, getting vaccinated can boost your body's protection against catching the virus that causes COVID-19 another time. Getting COVID-19 or getting a COV ...

Pfizer-BioNTech’s and Moderna’s mRNA-based COVID ... under an FDA priority review. Krazati just recently joined BMS’ arsenal after the company bought its maker, Mirati Therapuetics, for up ...

Anthropic’s co-founder and C.E.O. explains why he thinks artificial intelligence is on an “exponential curve.” ...

As a dietitian and mom of three kids under 5, my mornings can get pretty hectic. I'm always looking for easy breakfast meals and decided to try Ree Drummond's overnight oats. The recipe was easy ...

Pfizer announced positive results from a pivotal clinical trial evaluating Abrysvo's efficacy against respiratory syncytial ...

opens new tab copied its COVID-19 vaccine technology will be put ... Representatives for Pfizer and BioNTech did not immediately respond to requests for comment. Moderna accused Pfizer and ...

COVID era, emphasizing innovation, oncology, and AI in drug development for potential growth. Learn more on PFE stock here.

Pfizer (NYSE: PFE) stock is relatively cheap. I can easily back up that claim. The big drugmaker's shares trade at lower forward earnings multiples than the S&P 500 and the S&P 500 healthcare sector.

Around 3.2 million children between six and 59 months across the country ... Regular supplementation campaigns are estimated to have reduced deaths among children under five by 23 percent. Deworming ...

Pfizer will also have to address the issue “of adverse effects of the vaccines against the so-called Covid-19. In general, and also in detail in relation to the child population,” according to ...

But what if it were possible to protect against COVID and the flu, and other unknown viruses that haven't yet emerged, with ...